Bristol-Myers Squibb (BMY)
61.12
1.10 (1.83%)
At close: Mar 31, 2025, 3:59 PM
60.87
-0.40%
After-hours: Mar 31, 2025, 07:46 PM EDT
Reblozyl Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Jun 30, 2023 | 234M | 28M | +13.59% |
| Mar 31, 2023 | 206M | 7M | +3.52% |
| Dec 31, 2022 | 199M | 9M | +4.74% |
| Sep 30, 2022 | 190M | 18M | +10.47% |
| Jun 30, 2022 | 172M | -2.63B | -93.85% |
| Mar 31, 2022 | 2.8B | 2.24B | +403.96% |
| Dec 31, 2021 | 555M | 4M | +0.73% |
| Sep 30, 2021 | 551M | 10M | +1.85% |
| Jun 30, 2021 | 541M | 523M | +2905.56% |
| Mar 31, 2021 | 18M | 9M | +100.00% |
| Dec 31, 2020 | 9M | 7M | +350.00% |
| Sep 30, 2020 | 2M | n/a | n/a |
| Jun 30, 2020 | n/a | n/a | n/a |
| Mar 31, 2020 | n/a | n/a | n/a |
| Dec 31, 2019 | n/a | n/a | n/a |
| Sep 30, 2019 | n/a | n/a | n/a |
| Jun 30, 2019 | n/a | n/a | n/a |
| Mar 31, 2019 | n/a | n/a | n/a |
| Dec 31, 2018 | n/a | n/a | n/a |
| Sep 30, 2018 | n/a | n/a | n/a |
| Jun 30, 2018 | n/a | n/a | n/a |
| Mar 31, 2018 | n/a | n/a | n/a |
| Dec 31, 2017 | n/a | n/a | n/a |
| Sep 30, 2017 | n/a | n/a | n/a |
| Jun 30, 2017 | n/a | n/a | n/a |
| Mar 31, 2017 | n/a | n/a | n/a |
| Dec 31, 2016 | n/a | n/a | n/a |
| Sep 30, 2016 | n/a | n/a | n/a |
| Jun 30, 2016 | n/a | n/a | n/a |
| Mar 31, 2016 | n/a | n/a | n/a |
| Dec 31, 2015 | n/a | n/a | n/a |
| Sep 30, 2015 | n/a | n/a | n/a |
| Jun 30, 2015 | n/a | n/a | n/a |
| Mar 31, 2015 | n/a | n/a | n/a |
| Dec 31, 2014 | n/a | n/a | n/a |
| Sep 30, 2014 | n/a | n/a | n/a |
| Jun 30, 2014 | n/a | n/a | n/a |
| Mar 31, 2014 | n/a | n/a | n/a |
| Dec 31, 2013 | n/a | n/a | n/a |
| Sep 30, 2013 | n/a | n/a | n/a |
| Jun 30, 2013 | n/a | n/a | n/a |